KG&L Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,199
| Closed | -$275K | – | 207 |
|
|
2024
Q4 | $275K | Sell |
3,199
-664
| -17% | -$57.1K | 0.09% | 160 |
|
|
2024
Q3 | $460K | Sell |
3,863
-224
| -5% | -$26.7K | 0.15% | 131 |
|
|
2024
Q2 | $583K | Sell |
4,087
-75
| -2% | -$10.7K | 0.2% | 108 |
|
|
2024
Q1 | $534K | Buy |
4,162
+1,217
| +41% | +$156K | 0.21% | 103 |
|
|
2023
Q4 | $305K | Buy |
2,945
+19
| +0.6% | +$1.97K | 0.13% | 136 |
|
|
2023
Q3 | $266K | Buy |
2,926
+26
| +0.9% | +$2.36K | 0.13% | 129 |
|
|
2023
Q2 | $235K | Buy |
2,900
+20
| +0.7% | +$1.62K | 0.11% | 135 |
|
|
2023
Q1 | $229K | Sell |
2,880
-386
| -12% | -$30.7K | 0.12% | 119 |
|
|
2022
Q4 | $221K | Buy |
+3,266
| New | +$221K | 0.13% | 118 |
|
|
2022
Q3 | – | Sell |
-4,122
| Closed | -$230K | – | 133 |
|
|
2022
Q2 | $230K | Sell |
4,122
-1,620
| -28% | -$90.4K | 0.12% | 113 |
|
|
2022
Q1 | $319K | Sell |
5,742
-474
| -8% | -$26.3K | 0.13% | 109 |
|
|
2021
Q4 | $348K | Hold |
6,216
| – | – | 0.14% | 112 |
|
|
2021
Q3 | $298K | Buy |
6,216
+120
| +2% | +$5.75K | 0.13% | 120 |
|
|
2021
Q2 | $255K | Sell |
6,096
-6
| -0.1% | -$251 | 0.12% | 126 |
|
|
2021
Q1 | $206K | Sell |
6,102
-160
| -3% | -$5.4K | 0.1% | 125 |
|
|
2020
Q4 | $218K | Buy |
+6,262
| New | +$218K | 0.12% | 129 |
|